Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2885) 2885
Book Chapter (290) 290
Book / eBook (6) 6
Dissertation (6) 6
Conference Proceeding (3) 3
Magazine Article (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2343) 2343
life sciences & biomedicine (2244) 2244
humans (2148) 2148
idiopathic pulmonary fibrosis (1762) 1762
respiratory system (1624) 1624
male (1325) 1325
pulmonary fibrosis (1294) 1294
female (1256) 1256
middle aged (997) 997
aged (976) 976
lung diseases (725) 725
respiratory tract diseases (675) 675
prognosis (543) 543
general & internal medicine (518) 518
mortality (517) 517
fibrosis (514) 514
retrospective studies (446) 446
interstitial lung disease (429) 429
idiopathic pulmonary fibrosis - mortality (423) 423
abridged index medicus (414) 414
adult (397) 397
risk factors (395) 395
idiopathic pulmonary fibrosis - physiopathology (392) 392
idiopathic pulmonary fibrosis - diagnosis (387) 387
care and treatment (369) 369
idiopathic pulmonary fibrosis - drug therapy (369) 369
pneumonia (368) 368
disease progression (341) 341
research (339) 339
critical care medicine (337) 337
idiopathic pulmonary fibrosis - pathology (330) 330
patients (327) 327
treatment outcome (323) 323
biological and medical sciences (320) 320
medical sciences (320) 320
analysis (299) 299
animals (299) 299
aged, 80 and over (287) 287
lung - pathology (279) 279
diagnosis (266) 266
pneumology (263) 263
biopsy (252) 252
medical prognosis (238) 238
lungs (232) 232
health aspects (229) 229
development and progression (226) 226
tomography, x-ray computed (224) 224
cardiovascular system & cardiology (218) 218
pulmonary/respiratory (214) 214
cardiac & cardiovascular systems (210) 210
idiopathic pulmonary fibrosis - therapy (209) 209
studies (200) 200
medicine (199) 199
idiopathic pulmonary fibrosis - metabolism (196) 196
medicine & public health (190) 190
respiratory system : syndromes and miscellaneous diseases (190) 190
survival (188) 188
idiopathic pulmonary fibrosis - genetics (187) 187
bacterial pneumonia (185) 185
medicine, general & internal (183) 183
lung transplantation (182) 182
idiopathic pulmonary fibrosis - complications (181) 181
pulmonary hypertension (180) 180
medical research (177) 177
clinical trials (176) 176
survival analysis (176) 176
severity of illness index (174) 174
idiopathic pulmonary fibrosis - epidemiology (173) 173
survival rate (173) 173
research article (172) 172
chronic obstructive pulmonary disease (170) 170
respiratory function tests (170) 170
diseases of the respiratory system (167) 167
pathogenesis (162) 162
proteins (159) 159
usual interstitial pneumonia (159) 159
internal medicine (154) 154
pirfenidone (154) 154
vital capacity (154) 154
review (151) 151
usage (151) 151
lung cancer (150) 150
medicine, experimental (147) 147
mice (147) 147
acute exacerbation (146) 146
lung - physiopathology (146) 146
idiopathic pulmonary fibrosis - diagnostic imaging (145) 145
pyridones - therapeutic use (144) 144
follow-up studies (139) 139
time factors (138) 138
quality of life (137) 137
idiopathic interstitial pneumonia (134) 134
patient outcomes (132) 132
pharmacology & pharmacy (132) 132
fibroblasts (131) 131
pulmonary and respiratory medicine (131) 131
original (130) 130
gene expression (129) 129
cell biology (127) 127
surgery (127) 127
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3131) 3131
Korean (18) 18
Portuguese (15) 15
German (14) 14
Spanish (14) 14
French (11) 11
Chinese (9) 9
Japanese (8) 8
Dutch (3) 3
Italian (3) 3
Turkish (3) 3
Czech (1) 1
Danish (1) 1
Norwegian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Idiopathic pulmonary fibrosis and emphysema: Decreased survival associated with severe pulmonary arterial hypertension
by Mejía, Mayra and Carrillo, Guillermo and Rojas-Serrano, Jorge and Estrada, Andrea and Suárez, Teresa and Alonso, Delfino and Barrientos, Emilio and Gaxiola, Miguel and Navarro, Carmen and Selman, Moisés
Chest, ISSN 0012-3692, 07/2009, Volume 136, Issue 1, pp. 10 - 15
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Respiratory system : syndromes and miscellaneous diseases | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Chronic obstructive pulmonary disease, asthma | Pneumology | Hypertension, Pulmonary - mortality | Pulmonary Emphysema - physiopathology | Prevalence | Pulmonary Ventilation | Humans | Middle Aged | Risk Factors | Hypertension, Pulmonary - physiopathology | Male | Survival Rate | Pulmonary Artery | Case-Control Studies | Idiopathic Pulmonary Fibrosis - mortality | Female | Aged | Idiopathic Pulmonary Fibrosis - complications | Idiopathic Pulmonary Fibrosis - physiopathology | Pulmonary Emphysema - epidemiology | Pulmonary Emphysema - mortality | Cohort Studies | Hypertension, Pulmonary - complications | Smoking | Complications and side effects | Pulmonary fibrosis | Prognosis | Emphysema, Pulmonary | Development and progression | Comparative analysis | Pulmonary hypertension | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Idiopathic Pulmonary Fibrosis . Relationship between Histopathologic Features and Mortality
by KING, TALMADGE E., JR and SCHWARZ, MARVIN I and BROWN, KEVIN and TOOZE, JANET A and COLBY, THOMAS V and WALDRON, JAMES A., JR and FLINT, ANDREW and THURLBECK, WILLIAM and CHERNIACK, REUBEN M
American journal of respiratory and critical care medicine, ISSN 1073-449X, 09/2001, Volume 164, Issue 6, pp. 1025 - 1032
Usual interstitial pneumonia | Prospective studies | Survival rate | Pulmonary fibrosis physiopathology | Smoking physiopathology | Idiopathic pulmonary fibrosis | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Multivariate Analysis | Prognosis | Prospective Studies | Age Factors | Lung Diseases, Interstitial - pathology | Humans | Middle Aged | Male | Lung Diseases, Interstitial - mortality | Time Factors | Smoking - physiopathology | Adult | Female | Pulmonary Gas Exchange | Lung Diseases, Interstitial - physiopathology | Pulmonary Fibrosis - mortality | Lung - pathology | Proportional Hazards Models | Pulmonary Fibrosis - pathology | Biopsy | Pulmonary Fibrosis - physiopathology | Sex Factors | Survival Analysis | Aged | Respiratory Function Tests | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text All-cause mortality rate in patients with idiopathic pulmonary fibrosis: Implications for the design and execution of clinical trials
by King Jr, Talmadge E and Albera, Carlo and Bradford, Williamson Z and Costabel, Ulrich and Du Bois, Roland M and Leff, Jonathan A and Nathan, Steven D and Sahn, Steven A and Valeyre, Dominique and Noble, Paul W
American journal of respiratory and critical care medicine, ISSN 1073-449X, 04/2014, Volume 189, Issue 7, pp. 825 - 831
Endpoints | Clinical trial | Hospitalization | Idiopathic pulmonary fibrosis | Mortality | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Recombinant Proteins - therapeutic use | Follow-Up Studies | Interferon-gamma - therapeutic use | Randomized Controlled Trials as Topic - methods | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Models, Statistical | Cause of Death | Clinical Trials, Phase III as Topic - methods | Feasibility Studies | Sample Size | Idiopathic Pulmonary Fibrosis - mortality | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Aged, 80 and over | Adult | Female | Aged | Pyridones - therapeutic use | Research Design | Idiopathic Pulmonary Fibrosis - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis
by Richards, Thomas J and Kaminski, Naftali and Baribaud, Fred and Flavin, Susan and Brodmerkel, Carrie and Horowitz, Daniel and Li, Katherine and Choi, Jiin and Vuga, Louis J and Lindell, Kathleen O and Klesen, Melinda and Zhang, Yingze and Gibson, Kevin F
American journal of respiratory and critical care medicine, ISSN 1073-449X, 01/2012, Volume 185, Issue 1, pp. 67 - 76
Biomarkers | Adhesion molecules | MMP-7 | Personalized medicine | Mortality prediction | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | Intensive care medicine | Medical sciences | Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy | Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis | Transfusions. Complications. Transfusion reactions. Cell and gene therapy | Cell Adhesion Molecules - blood | Enzyme-Linked Immunosorbent Assay - methods | Predictive Value of Tests | Matrix Metalloproteinase 7 - blood | Humans | Proportional Hazards Models | Male | Biomarkers - blood | Idiopathic Pulmonary Fibrosis - blood | S100A12 Protein | Vascular Cell Adhesion Molecule-1 - blood | Matrix Metalloproteinase 1 - blood | Idiopathic Pulmonary Fibrosis - mortality | S100 Proteins - blood | Survival Analysis | Female | Intercellular Adhesion Molecule-1 - blood | Aged | Interleukin-8 - blood | Matrix Metalloproteinases - blood | Cohort Studies | Index Medicus | Abridged Index Medicus | mortality prediction | adhesion molecules | biomarkers | personalized medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Global incidence and mortality of idiopathic pulmonary fibrosis: A systematic review
by Hutchinson, John and Fogarty, Andrew and Hubbard, Richard and McKeever, Tricia
The European respiratory journal, ISSN 0903-1936, 09/2015, Volume 46, Issue 3, pp. 795 - 806
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Severity of Illness Index | Global Health | Humans | Middle Aged | Europe - epidemiology | Male | Cause of Death | Incidence | Idiopathic Pulmonary Fibrosis - epidemiology | South America - epidemiology | Idiopathic Pulmonary Fibrosis - diagnosis | Survival Analysis | Adult | Female | Aged | North America - epidemiology
Journal Article
Details down arrow
6. Full Text Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
by Richeldi, Luca and Cottin, Vincent and du Bois, Roland M and Selman, Moisés and Kimura, Toshio and Bailes, Zelie and Schlenker-Herceg, Rozsa and Stowasser, Susanne and Brown, Kevin K
Respiratory medicine, ISSN 0954-6111, 2016, Volume 113, pp. 74 - 79
Pulmonary/Respiratory | Acute exacerbations | Forced vital capacity | Mortality | Disease progression | Quality of life | Cardiac & Cardiovascular Systems | Respiratory System | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Drug Administration Schedule | Humans | Middle Aged | Enzyme Inhibitors - pharmacology | Male | Treatment Outcome | Diarrhea - chemically induced | Indoles - administration & dosage | Randomized Controlled Trials as Topic | Enzyme Inhibitors - administration & dosage | Vital Capacity - drug effects | Clinical Trials, Phase III as Topic | Female | Indoles - pharmacology | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Clinical Trials, Phase II as Topic | Pulmonary fibrosis | Lung diseases | Data collection | Diarrhea | Pharmaceutical industry | Drug dosages | Growth factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Forced Vital Capacity in Idiopathic Pulmonary Fibrosis — FDA Review of Pirfenidone and Nintedanib
by Karimi-Shah, Banu A and Chowdhury, Badrul A
The New England journal of medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1189 - 1191
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | United States | Humans | Enzyme Inhibitors - pharmacology | Drug Approval | Enzyme Inhibitors - therapeutic use | Cause of Death | Advisory Committees | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Vital Capacity - drug effects | Idiopathic Pulmonary Fibrosis - mortality | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Indoles - pharmacology | Indoles - therapeutic use | Idiopathic Pulmonary Fibrosis - physiopathology | Pyridones - therapeutic use | Idiopathic Pulmonary Fibrosis - drug therapy | Pyridones - pharmacology | United States Food and Drug Administration | Studies | Pulmonary fibrosis | Mortality | Lung diseases | Fibrosis | FDA approval | Drug therapy | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
by Lettieri, Christopher J and Nathan, Steven D and Barnett, Scott D and Ahmad, Shahzad and Shorr, Andrew F
Chest, ISSN 0012-3692, 03/2006, Volume 129, Issue 3, pp. 746 - 752
PFT = pulmonary function test | pulmonary artery | pulmonary hypertension | catheterization | PA = pulmonary artery | CI = confidence interval | PAH = pulmonary arterial hypertension | exercise test | ILD = interstitial lung disease | LV = left ventricular | mPAP = mean pulmonary arterial pressure | 6MWT = 6-min walk test | pulmonary fibrosis | mortality | pulmonary function tests | Dlco = diffusing capacity of the lung for carbon monoxide | IPF = idiopathic pulmonary fibrosis | HR = hazard ratio | Spo2 = pulse oximetric saturation | PAWP = pulmonary artery wedge pressure | TLC = total lung capacity | Pulmonary fibrosis | Catheterization | Mortality | Pulmonary function tests | Exercise test | Pulmonary artery | Pulmonary hypertension | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Pulmonary hypertension. Acute cor pulmonale. Pulmonary embolism. Pulmonary vascular diseases | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Pulmonary Fibrosis - mortality | Spirometry | Hypertension, Pulmonary - diagnosis | Prevalence | Comorbidity | Pulmonary Fibrosis - complications | Humans | Middle Aged | Proportional Hazards Models | Male | Hypertension, Pulmonary - epidemiology | Pulmonary Fibrosis - epidemiology | Exercise Test | Sensitivity and Specificity | Survival Analysis | Female | Hypertension, Pulmonary - etiology | Causes of | Patient outcomes | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The rising incidence of idiopathic pulmonary fibrosis in the UK
by Navaratnam, V and Fleming, K M and West, J and Smith, C J P and Jenkins, R G and Fogarty, A and Hubbard, R B
Thorax, ISSN 0040-6376, 06/2011, Volume 66, Issue 6, pp. 462 - 467
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Cardiology. Vascular system | Biological and medical sciences | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Idiopathic Pulmonary Fibrosis - epidemiology | Age Distribution | Idiopathic Pulmonary Fibrosis - mortality | Primary Health Care - statistics & numerical data | Epidemiologic Methods | Humans | Middle Aged | Aged, 80 and over | Sex Distribution | Aged | Mortality - trends | United Kingdom - epidemiology | Development and progression | Pulmonary fibrosis | Diagnosis | Patient outcomes | Codes | Mortality | Lung diseases | Studies | Datasets | Databases | Medical prognosis | Population | Trends | Age | Cancer | Chronic illnesses | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
by Gribbin, J and Hubbard, R B and Le Jeune, I and Smith, C J P and West, J and Tata, L J
Thorax, ISSN 0040-6376, 11/2006, Volume 61, Issue 11, pp. 980 - 985
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Biological and medical sciences | Medical sciences | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Pulmonary Fibrosis - mortality | Prevalence | Sarcoidosis, Pulmonary - mortality | Humans | Middle Aged | Male | Pulmonary Fibrosis - epidemiology | Incidence | Sarcoidosis, Pulmonary - epidemiology | Survival Analysis | Aged, 80 and over | Adult | Female | Poisson Distribution | Aged | United Kingdom - epidemiology | Cohort Studies | Pulmonary fibrosis | Demographic aspects | Sarcoidosis | Mortality | United Kingdom | Reports | Statistics | Disease | Medical prognosis | Population | Software | Workloads | Age | Family physicians | Index Medicus | Interstitial Lung Disease | epidemiology | sarcoidosis | idiopathic pulmonary fibrosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Baseline characteristics of idiopathic pulmonary fibrosis: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
by Jo, Helen E and Glaspole, Ian and Grainge, Christopher and Goh, Nicole and Hopkins, Peter M.A and Moodley, Yuben and Reynolds, Paul N and Chapman, Sally and Walters, E. Haydn and Zappala, Christopher and Allan, Heather and Keir, Gregory J and Hayen, Andrew and Cooper, Wendy A and Mahar, Annabelle M and Ellis, Samantha and Macansh, Sacha and Corte, Tamera J
The European respiratory journal, ISSN 0903-1936, 02/2017, Volume 49, Issue 2, pp. 1601592 - 1601592
Life Sciences & Biomedicine | Respiratory System | Science & Technology | Multivariate Analysis | Age Distribution | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Lung - physiopathology | Australia - epidemiology | Vital Capacity | Idiopathic Pulmonary Fibrosis - mortality | Survival Analysis | Aged, 80 and over | Adult | Carbon Monoxide - blood | Female | Registries | Aged | Idiopathic Pulmonary Fibrosis - physiopathology | Idiopathic Pulmonary Fibrosis - drug therapy | Respiratory function | Pulmonary fibrosis | Mortality | Lung diseases | Fibrosis | Population studies | Physiology | Carbon monoxide | Age
Journal Article
Details down arrow
12. Full Text Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
by Noble, Paul W, Prof and Albera, Carlo, Prof and Bradford, Williamson Z, MD and Costabel, Ulrich, Prof and Glassberg, Marilyn K, MD and Kardatzke, David, PhD and King, Talmadge E, Prof and Lancaster, Lisa, MD and Sahn, Steven A, Prof and Szwarcberg, Javier, MD and Valeyre, Dominique, Prof and du Bois, Roland M, Prof and for the CAPACITY Study Group and CAPACITY Study Grp and CAPACITY Study Group
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9779, pp. 1760 - 1769
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Biological and medical sciences | General aspects | Medical sciences | Respiratory system : syndromes and miscellaneous diseases | Pneumology | Follow-Up Studies | Administration, Oral | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Dose-Response Relationship, Drug | Vital Capacity - drug effects | Disease-Free Survival | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Idiopathic Pulmonary Fibrosis - mortality | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Female | Aged | Pyridones - therapeutic use | Idiopathic Pulmonary Fibrosis - drug therapy | Pyridones - adverse effects | Usage | Care and treatment | Pulmonary fibrosis | Diagnosis | Research | Health aspects | Antifibrinolytic agents | Studies | Clinical trials | Lungs | Lung diseases | Regulatory approval | Index Medicus | Abridged Index Medicus | antiinflammatory agents | Respiratory function | Lung | Mortality | Anti-Inflammatory Agents, Non-Steroidal | Pyridones | Idiopathic Pulmonary Fibrosis | Life Sciences | Vital Capacity | Human health and pathology | Pulmonology and respiratory tract
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights